CelLBxHealth plc
Research CelLBxHealth plc (CLBX) on Bullrun: market cap GBX 1.51B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCLBX
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyGBX
- Market capGBX 1.51B
- Financial periodFY2025
- RevenueGBP 1.35M
- Revenue growth-52.8%
- Net income-GBP 19.51M
- Free cash flow-GBP 9.51M
- Gross margin61.6%
Valuation Snapshot
latest market cap is GBX 1.51B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 1.35M | -GBP 19.51M | -GBP 9.51M | 61.6% | -0.06 | GBP 7.35M | GBP 1.82M | GBP 7.20M |
| FY2024 | GBP 2.86M | -GBP 14.23M | -GBP 13.89M | 62.2% | -0.05 | GBP 10.43M | GBP 4.21M | GBP 18.44M |
| FY2023 | GBP 2.19M | -GBP 20.13M | -GBP 15.12M | 69.9% | -0.08 | GBP 16.22M | GBP 4.55M | GBP 22.94M |
| FY2022 | GBP 1.04M | -GBP 21.69M | -GBP 17.94M | 58.9% | -0.09 | GBP 31.90M | GBP 5.00M | GBP 40.06M |
| FY2021 | GBP 1.01M | -GBP 15.01M | -GBP 15.80M | 70.2% | -0.07 | GBP 31.84M | GBP 2.34M | GBP 40.33M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-17 | GBX 1.51B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About CelLBxHealth plc
CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix platform, emables real-time multiomic insights from blood. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal circulating tumour cells;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is CelLBxHealth plc's market cap?
CelLBxHealth plc's market capitalization is GBX 1.51B.
What does CelLBxHealth plc do?
CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix platform, emables real-time multiomic insights from blood. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal circulating tumour cells; and CellKeep Slide, a CTC harvesting technology.